Similarly, the proinflammatory cytokine IL-6 was found to be elevated in MPN patients and in murine models, and neutralizing antibodies specific to IL-6 or its genetic deletion reduced erythropoiesis and myeloproliferation [87]. Here, IL6 is linked to myeloproliferative disorder.